Navigation Links
Stemline Therapeutics' Lead Clinical Candidate SL-401 Induces a Complete Response in a Patient with a Drug-Refractory Plasmacytoid Dendritic Cell Neoplasm
Date:11/8/2012

ine Therapeutics, Inc. is a clinical stage biopharmaceutical company developing novel oncology therapeutics that target both cancer stem cells (CSCs) as well as the tumor bulk. Among Stemline's drug candidates are SL-401 and SL-701, both of which have demonstrated single agent clinical activity in Phase 1/2 studies of advanced cancer patients. In a multicenter Phase 1/2 trial in patients with advanced acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), SL-401 demonstrated single agent activity, including durable complete responses (CRs), and an overall survival (OS) improvement relative to historical data in the most heavily pretreated AML patients. In addition, SL-401 was well-tolerated and was not toxic to the bone marrow. SL-401 is being advanced into later stage trials in advanced AML. In Phase 1/2 trials, Stemline's second clinical stage therapeutic, SL-701, has demonstrated single agent activity including durable CRs and partial responses (PRs) in adult patients with refractory or recurrent glioblastoma and pediatric patients with malignant glioma, as well as an OS benefit in adult patients with refractory or recurrent glioblastoma compared with historical data. SL-701 is now poised for later stage trials in pediatric and adult patients with advanced brain cancer. Stemline is also developing a broad portfolio of preclinical small molecules and antibodies for a variety of solid and hematological cancer types. Many of these compounds have derived from the Company's proprietary discovery platform, StemScreen®. For more information, please visit the Company's website at www.stemline.com.

Stemline Contact:

Mark Jacobson
Director, Corporate Development
Stemline Therapeutics, Inc.
750 Lexington Avenue
Sixth Floor
New York, NY 10022
Tel: 646-502-2307
Email: mjacobson@stemline.com
www.steml
'/>"/>

SOURCE Stemline Therapeutics, Inc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
2. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
3. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
4. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
5. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
6. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
7. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
8. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
9. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
10. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
11. New Forecast Shows Global Protein Therapeutics Market to Reach $143.4 Billion by 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... 1, 2015 Inventor of ... ana team   NuCana, a clinical ... and commercialise a portfolio of novel anti-cancer medicines, today ... as Chief Scientific Officer. Professor McGuigan was ... currently Professor of Medicinal Chemistry at the Cardiff School ...
(Date:6/30/2015)... June 30, 2015 Nortek Security & ... NTK ) and a leader in the residential ... announced it acquired mobile personal emergency response system ... Numera, Inc. Headquartered in ... implemented, mobile PERS products and cloud-based software platforms ...
(Date:6/30/2015)... 2015   Millar, Inc. , a leader in ... 2016 retirement of Craig Thummel , President/CEO and ... of service to the Company. The Company also announced ... of the Executive Management team as his successors. The ... currently Director of Sales and Marketing, as President, and ...
Breaking Medicine Technology:Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 2Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 3Nortek Security & Control Acquires Health and Wellness Technology Business from Numera 2Nortek Security & Control Acquires Health and Wellness Technology Business from Numera 3Nortek Security & Control Acquires Health and Wellness Technology Business from Numera 4Millar, Inc. Announces Leadership Changes 2Millar, Inc. Announces Leadership Changes 3
(Date:7/1/2015)... , ... July 01, 2015 , ... Franklin University, one ... Dr. Leslie King has been named Dean of the College of ... Dr. King will promote and support the vision and mission of Franklin University via ...
(Date:7/1/2015)... ... ... Francesca Camp wasn’t always a steadfast supporter of plastic surgery. But just as ... the practice; a terrible car accident years ago left her injured and in need of ... ? (And What if I Do?): Answers to All Your Questions about Plastic Surgery” (published ...
(Date:7/1/2015)... ... ... Research published in the journal JAMA Ophthamology showed that using ... accurate as those from standard paper-based charts and illuminated vision boxes found in eye ... of the test, which does not depend on traditional familiarity with the symbols and ...
(Date:7/1/2015)... ... July 01, 2015 , ... The executive ... and marketing of a number of nutritional and beauty products, announced the company ... ECRM Diet, Vitamin & Sports Nutrition conference in Tampa, Florida. This specific ECRM ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... Nutritional Products ... of nutritional and beauty products, recently attended the 2015 ECRM Diet, Vitamin & Sports ... in the retail industry. The ECRM trade show allows companies the chance ...
Breaking Medicine News(10 mins):Health News:Franklin University Appoints Dean of College of Health & Public Administration 2Health News:Francesca Camp’s New Book Unmasks Plastic Surgery Advice 2Health News:New Research Shows Reliability of Peek Eye Testing Mobile App 2Health News:New Research Shows Reliability of Peek Eye Testing Mobile App 3Health News:NPI Executives Report Great Success at ECRM Conference 2Health News:NPI Meets With Top Retail Figures at ECRM Conference 2
... for its abundant health benefits. Now, British scientists, armed ... of a vital element in green tea, which may ... in the Journal of Allergy and Clinical Immunology. ... discovered that an important element in green tea called ...
... report that freezing kidney tumors through percutaneous cryoablation shows ... surgery. Their early findings showing short-term success in more ... this month’s issue of Radiology. ,The standard ... likelihood of a long-term cure. For some patients, surgery ...
... 5 million people in the United States living with the ... of them are at the early stages, struggling to pass ... changes in personality and behavior, such as anxiety, suspiciousness or ... ,Up to five years though, those with the affliction could ...
... Duke University Medical Center,// obese persons diagnosed with prostate ... than their biopsies would predict. ,The ... many obese and overweight men to receive inadequate or ... the true nature of their disease, said study leader ...
... Pharmaceutical Producers of India (OPPI) has demanded that the federal ... levied on certain life-saving drugs. ,In ... Finance Minister P.Chidambaram had proposed a five per cent tax ... though. ,In a memorandum submitted to the ...
... go through ‘one of the most stressful things’ of his life, ... acoustic neuroma - a form of brain tumour in the inner ... brain surgery was to begin. , It was then ... use during operation. The team of 30 professionals as well as ...
Cached Medicine News:Health News:Cryoablation: A New Treatment Option for Some Kidney Tumor Patients 2Health News:Cryoablation: A New Treatment Option for Some Kidney Tumor Patients 3Health News:Alzheimer’s Patients Plead for Greater Understanding and Suppor 2Health News:Obesity Does Not Auger Well for Prostate Cancer Patients 2Health News:Obesity Does Not Auger Well for Prostate Cancer Patients 3
This camouflaging lens features the solid black stripes of the lightning fast African zebra, on a white iris background....
Sphere Introducer...
Reusable cannula with .90 mm (20 g) shaft, tapering to .30 mm (30 g). Angled 125 3 mm from tip and flattened for easy insertion into the subretinal space....
... tip cannula allows atraumatic access ... for aspiration of subretinal fluids. ... beyond end of cannula. ... secure connection to a backflush ...
Medicine Products: